Antibody-induced internalization of the human respiratory syncytial virus fusion protein by Leemans, Alexander et al.
Antibody-induced internalization of the human respiratory syncytial
virus fusion protein
Leemans, A., De Schryver, M., Van der Gucht, W., Heykers, A., Pintelon, I., Hotard, A. L., ... Delputte, P. (2017).
Antibody-induced internalization of the human respiratory syncytial virus fusion protein. Journal of Virology. DOI:
10.1128/JVI.00184-17
Published in:
Journal of Virology
Document Version:
Peer reviewed version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© 2017 American Society for Microbiology. This work is made available online in accordance with the publisher’s policies. Please refer to any
applicable terms of use of the publisher.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:06. Nov. 2017
1 
 
Antibody-induced internalization of the human respiratory syncytial virus 1 
fusion protein  2 
Leemans A1, De Schryver M1, Van der Gucht W1, Heykers A1, Pintelon I2, Hotard AL3, Moore 3 
ML3,4, Melero JA5, McLellan JS6, Graham BS7, Broadbent L8, Power UF8, Caljon G1, Cos P1, 4 
Maes L1, Delputte P1# 5 
 6 
1 Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Antwerp, 7 
Belgium 8 
2 Laboratory of Cell Biology and Histology, University of Antwerp, Antwerp, Belgium 9 
3 Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United 10 
States of America 11 
4 Children's Healthcare of Atlanta, Atlanta, Georgia, United States of America 12 
5 Centro Nacional de Microbiología and CIBER de Enfermedades Respiratorias, Instituto de 13 
Salud Carlos III, Majadahonda, Madrid, Spain 14 
6 Department of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, New 15 
Hampshire, United States of America 16 
7 Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National 17 
Institutes of Health, Bethesda, Maryland, United States of America 18 
8 Centre for Infection & Immunity, School of Medicine, Dentistry & Biomedical Sciences, 19 
Queen's University Belfast, Belfast, United Kingdom 20 
#Corresponding author. Laboratory of Microbiology, Parasitology and Hygiene, University of 21 
Antwerp, Universiteitsplein 1, 2610 Antwerpen, Belgium 22 
Tel: +32 3 265 26 25 23 
E-mail address: peter.delputte@uantwerpen.be 24 
JVI Accepted Manuscript Posted Online 3 May 2017
J. Virol. doi:10.1128/JVI.00184-17
Copyright © 2017 American Society for Microbiology. All Rights Reserved.
 o
n
 M
ay 9, 2017 by QUEEN'S UNIVERSITY BELFAST
http://jvi.asm.org/
D
ow
nloaded from
 
2 
 
Running title: Antibody-induced RSV F protein internalization 25 
Abstract: 392 words  26 
Text:   5030 words  27 
 o
n
 M
ay 9, 2017 by QUEEN'S UNIVERSITY BELFAST
http://jvi.asm.org/
D
ow
nloaded from
 
3 
 
ABSTRACT 28 
 29 
Respiratory syncytial virus (RSV) infections remain a major cause of respiratory disease and 30 
hospitalizations among infants. Infection recurs frequently and establishes a weak and short-lived 31 
immunity. To date, RSV immunoprophylaxis and vaccine research is mainly focused on the RSV 32 
fusion (F) protein, but a vaccine remains elusive. The RSV F protein is a highly conserved 33 
surface glycoprotein and the main target of neutralizing antibodies induced by natural infection. 34 
Here, we analyzed an internalization process of antigen–antibody complexes after binding of 35 
RSV-specific antibodies to RSV antigens expressed on the surface of infected cells. The RSV F 36 
protein and attachment (G) protein were found to be internalized in both infected and transfected 37 
cells after the addition of either RSV-specific polyclonal antibodies (pAbs) or RSV glycoprotein-38 
specific monoclonal antibodies (mAbs), as determined by indirect immunofluorescence staining 39 
and flow-cytometric analysis. Internalization experiments with different cell lines, well-40 
differentiated primary bronchial epithelial cells (WD-PBECs) and RSV isolates suggest that 41 
antibody-internalization can be considered as a general feature of RSV. More specifically for 42 
RSV F, the mechanism of internalization was shown to be clathrin-dependent. All RSV F-43 
targeted mAbs tested, regardless of their epitopes, induced internalization of RSV F. No 44 
differences could be observed between the different mAbs, indicating that RSV F internalization 45 
was epitope-independent. Since this process can be either antiviral, by affecting virus assembly 46 
and production, or beneficial for the virus, by limiting the efficacy of antibodies and effector 47 
mechanism, further research is required to determine the extent to which this occurs in vivo and 48 
how this might impact RSV replication. 49 
 50 
  51 
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IMPORTANCE 52 
 53 
Current research into the development of new immunoprophylaxis and vaccines is mainly 54 
focused on the RSV F protein since, among others, RSV F-specific antibodies are able to protect 55 
infants from severe disease, if administered prophylactically. However, antibody responses 56 
established after natural RSV infections are poorly protective against reinfection and high levels 57 
of antibodies do not always correlate with protection. Therefore, RSV might be capable of 58 
interfering, at least partially, with antibody-induced neutralization. In this study, a process 59 
through which surface-expressed RSV F proteins are internalized after interaction with RSV-60 
specific antibodies is described. One the one hand, this antigen–antibody complex internalization 61 
could result in an antiviral effect, since it may interfere with virus particle formation and virus 62 
production. On the other hand, this mechanism may also reduce the efficacy of antibody-63 
mediated effector mechanisms towards infected cells.  64 
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INTRODUCTION 65 
 66 
Human respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract 67 
disease in young children and a major cause in the elderly and immunocompromised patients 68 
worldwide (1, 2). Nearly all children are exposed to RSV by two years of age, and prematurity, 69 
bronchopulmonary dysplasia and congenital heart disease are risk factors for developing severe 70 
RSV disease, including bronchiolitis and pneumonia (1). RSV may also cause significant disease 71 
in adults and furthermore re-infection can occur throughout life (2). Despite the discovery of the 72 
virus in 1956, no safe and effective vaccine is currently available to control RSV infections (3). 73 
Treatment of severe infections is primarily supportive by maintenance of hydration and 74 
oxygenation. Palivizumab, a humanized monoclonal antibody, targets a conserved epitope of the 75 
RSV fusion (F) protein and is administered prophylactically to high-risk patients (4). Severe RSV 76 
disease appears to be linked to an unbalanced and incomplete immune response. Several factors 77 
that allow RSV to evade host defense have already been described (2, 5, 6). 78 
RSV belongs to the Pneumoviridae, genus Orthopneumovirus, which is comprised of enveloped 79 
viruses with a negative-stranded RNA genome. The 15.2 kb non-segmented genome is comprised 80 
of 10 genes that encode 11 proteins. Among these are three surface glycoproteins, the G 81 
glycoprotein, the F protein and the small hydrophobic (SH) protein (1). The G protein is 82 
responsible for attachment with host cells, which are predominantly ciliated airway epithelial 83 
cells (7, 8). Fusion of the viral and cellular membranes is facilitated by the RSV F protein, as is 84 
fusion between the membranes of infected cells with adjacent cells, which result in large, 85 
multinucleated syncytia. The smaller SH protein is considered to act like a viroporin and 86 
increases membrane permeability (5). Of these envelope glycoproteins, only the RSV F protein is 87 
indispensable for viral replication in vitro (9). It is the most conserved RSV glycoprotein and also 88 
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the main target of neutralizing antibodies and vaccine development (10, 11). Initially, the RSV F 89 
protein assembles into a homotrimeric, metastable prefusion conformation that rearranges to a 90 
highly stable postfusion conformation during fusion of the viral and target cell membrane or 91 
spontaneously (12). Six major antigenic sites are currently identified that are located on the 92 
prefusion and/or postfusion trimer conformation of the RSV F protein (10, 13-15). Palivizumab, 93 
directed to antigenic site II, is the only approved immunoprophylaxis and provided a 55% 94 
reduction in RSV-associated hospitalizations in a phase III trial (16). At present, the use of potent 95 
neutralizing antibodies directed to other epitopes and/or targets is being extensively studied as 96 
alternative approaches for both therapy and prophylaxis. This research is mainly focused on 97 
highly potent antibodies that recognize the prefusion RSV F conformation. Three antibodies 98 
(5C4, AM22 and D25) were shown to bind the prefusion specific antigenic site Ø, located at the 99 
apex of the prefusion trimer (14). Recently, two novel prefusion-specific antibodies, MPE8 and 100 
AM14, were characterized and shown to bind antigenic sites III and V, respectively (10, 15, 17). 101 
The epitope for MPE8 is located near the binding site of palivizumab in the groove between the 102 
helix-turn-helix and the ridge of antigenic site IV on the adjacent protomer. It partially competes 103 
with mAbs to sites II, IV and V. This epitope is well-conserved between other pneumoviruses of 104 
the Paramyxoviridae family (15). Antigenic site V, targeted by AM14, spans from the tip of the 105 
β3-β4 hairpin of one protomer to the distal end of antigenic site IV on the adjacent protomer (17). 106 
Internalization of viral envelope proteins expressed on the surface of infected cells is a 107 
commonly seen characteristic of viruses, including paramyxoviruses (18-22). For most viruses, 108 
the relevance of this process is not yet fully understood. In the case of the Henipavirus fusion 109 
proteins, internalization from the surface is essential for proteolytic activation by cathepsin L 110 
(19). Also, virus assembly can be affected by the internalization of viral glycoproteins (23). 111 
Furthermore, internalization can be important for viral pathogenesis by down-regulation of viral 112 
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antigen surface expression and reduced recognition of infected cells by the immune system (20, 113 
24-26). Two different types of internalization have been described previously. Spontaneous 114 
endocytosis was observed for many herpesviruses and human immunodeficiency virus (HIV) 115 
among others. A second type of internalization is induced by the interaction of specific antibodies 116 
with viral proteins expressed on the surface of infected cells, followed by internalization of 117 
antibody-antigen complexes in the cell  (25, 27, 28). Such viral protein internalization may either 118 
result from cross-linking or depend on specific endocytic motifs in the cytoplasmic or 119 
transmembrane domains of glycoproteins, such as common tyrosine-based sorting motifs and di-120 
leucine motifs (20, 24, 29, 30). 121 
Previous studies have shown that upon binding of goat anti-RSV polyclonal antibodies (pAbs) 122 
to RSV antigens expressed on the surface of infected HEp-2 cells, internalization of these RSV 123 
antigen–antibody complexes may occur (31, 32). In this study, we examined this process in the 124 
context of a viral infection as well as at the level of individual RSV glycoproteins expressed at 125 
the surface of transfected cells. Both strategies demonstrated uptake of RSV antigen–antibody 126 
complexes in a time-dependent manner that resulted in a reduction of surface expressed RSV 127 
antigens. This process is modulating surface expression of RSV antigens and may affect 128 
induction of and recognition by RSV-specific antibodies. Since the RSV F protein elicits the most 129 
potent neutralizing antibodies and is currently the most interesting target for therapeutic and 130 
prophylactic purposes, this study aimed to characterize antibody-induced internalization of RSV 131 
antigens, in particular RSV F, in more detail. 132 
 133 
MATERIAL AND METHODS 134 
 135 
Cells, virus and antibodies 136 
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Human epidermoid carcinoma larynx cell line (HEp-2) and A549 cell line were obtained from 137 
ATCC. The cells were grown in Dulbecco’s modified Eagle medium (DMEM) and Ham’s F-12K 138 
(Kaighn's) medium respectively, both supplemented with 10% inactivated fetal bovine serum 139 
(iFBS) (Thermo Fisher Scientific). BSR T7/5 cells were a gift of K.K. Conzelmann (Max-von-140 
Pettenhofer-Institut, Munich, Germany) and grown in Glasgow’s minimal essential medium 141 
(GMEM) supplemented with 10% iFBS and 2% minimal essential amino acids (Thermo Fisher 142 
Scientific). Well-differentiated primary paediatric bronchial epithelial cell (WD-PBECs) culture 143 
was described previously (33). RSV reference strains A2, B1 and clinical isolate A1998/3-2 were 144 
obtained from the Biodefense and Emerging Infections Research Resources Repository (BEI 145 
resources) and propagated in HEp-2 cells. Recombinant RSV encoding the far-red fluorescent 146 
protein monomeric Katushka-2 (mKate2) was recovered as described previously (34). 147 
Commercially available goat anti-RSV pAb (Virostat), mouse anti-RSV F IgG (clone 131-2A; 148 
Millipore) and mouse anti-RSV G IgG (clone 131-2G; Millipore) were used as reference 149 
antibodies. Human reference antiserum was obtained from BEI resources (BEI NR-4020). A 150 
panel of RSV F-specific mAbs and their corresponding Fab fragment were provided by J.A. 151 
Melero, J.S McLellan, B.S. Graham and C.A.M. de Haan. Secondary antibodies donkey anti-goat 152 
IgG, chicken anti-mouse IgG and goat-anti human IgG, conjugated with Alexa Fluor (AF) 488 or 153 
555, obtained from Thermo Fisher Scientific and FITC-conjugated rabbit anti-human IgG 154 
(DAKO), were used to visualize the antigens. 155 
 156 
Construction and expression of recombinant RSV proteins 157 
Synthesis of the RSV F and RSV G protein was performed by Genscript and delivered in pUC57, 158 
a commonly used plasmid for cloning. Restriction enzymes (New England Biolabs) were used to 159 
subclone the recombinant sequences in a mammalian expression vector pBudCE4.1 (Thermo 160 
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Fisher Scientific). Transfection of the resulting plasmids was performed with Lipofectamine 2000 161 
(Thermo Fisher Scientific) in Opti-MEM (Thermo Fisher Scientific) to obtain surface expression 162 
of recombinant RSV proteins. Briefly, BSR T7/5 cells were seeded on coverslips in 24-well 163 
plates to be confluent at the time of transfection. Plasmid DNA was mixed with Lipofectamine 164 
2000 and incubated at room temperature during 20 min. Next, the transfection complexes were 165 
added to the cells and incubated for 2 h at room temperature. Further incubation at 37°C was 166 
performed after adding complete GMEM for 6 h. Finally, the complexes were removed, replaced 167 
by complete GMEM and incubated overnight at 37°C.  168 
 169 
Antibody-induced internalization assay 170 
Cells were seeded on coverslips in 24-well plates to be subconfluent or confluent at the time of 171 
infection or transfection respectively. RSV infection was performed by diluting the virus stock in 172 
basal growth medium and subsequently adding the virus suspension to the cells. After 2 h 173 
incubation at 37°C, the inoculum was removed and replaced by complete growth medium and 174 
further incubated at 37°C. Transfections were performed as described above. After 24 h 175 
incubation, RSV-infected or transfected cells were incubated with antibodies against RSV for  176 
1 h at 4°C to allow only attachment of the antibodies. To remove unbound antibody, cells were 177 
washed three times with growth medium, followed by incubation at 37°C to start the 178 
internalization process. After different time points, cells were fixed with 4% paraformaldehyde 179 
(Merck) and permeabilized with 0.5% Triton X-100 (Sigma-Aldrich). To visualize antigen–180 
antibody complexes, cells were stained with appropriate secondary antibodies conjugated with 181 
AF 488, AF 555 or FITC. As a control, cells were fixed after the 4°C incubation (T0). 182 
 183 
Flow-cytometric analysis of RSV internalization 184 
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Surface expression after internalization was quantified by flow cytometry. HEp-2 and A549 cells 185 
were seeded in 6-well plates to be subconfluent after 24 h incubation at 37°C or kept in 186 
suspension in pre-coated glass vials (Sigmacote®) for 24 h. Infection of the cells was performed 187 
as described above. After 24 h, infected cells in 6-well plates were detached by incubation with 1 188 
mM EDTA (Sigma) during 30 min at 4°C and pelleted by centrifugation (210 x g, 10 min, 4°C). 189 
The pellet was resuspended in RPMI supplemented with 10% iFBS, then incubated with primary 190 
antibodies during 1 h at 4°C and washed to remove unbound antibodies. Cells were kept at 4°C as 191 
timepoint 0. The other samples cells were then shifted to 37°C by the addition of warm RPMI 192 
medium and further incubated at 37°C during 90 min. To stop internalization, cells were shifted 193 
to 4°C for 15 min. Afterwards, the cells were incubated with AF 488-conjugated secondary 194 
antibodies for 1 h at 4°C, washed with PBS and analyzed by flow cytometry with a 195 
FACSCalibur. Dead cells were excluded by staining the cells with LIVE/DEAD® fixable far-red 196 
dead cell stain (Thermo Fisher Scientific). Forward-scattered light (FSC), side-scattered light, the 197 
AF 488 (FL-1) and far-red fluorescence signal (FL-4) were stored for further analysis. Mean 198 
fluorescence intensity (MFI) was calculated from three independent repeats. The reduction in 199 
surface expression was calculated as follows: 100 - [MFI90 min - MFIbackground] / [MFI0 min - 200 
MFIbackground] x 100 whereas MFIbackground is the mean of the fluorescence signal of stained non-201 
infected cells.  202 
 203 
Spontaneous endocytosis assay 204 
Infection of subconfluent HEp-2 cell cultures was performed as described above. Surface proteins 205 
of the infected cells were biotinylated using EZ-link Sulfo-NHS-SS-biotin (Thermo Fisher 206 
Scientific) at 4°C. Then, cells were incubated at 37°C to allow endocytosis to occur. As a control 207 
of antibody-induced internalization, one sample was incubated with RSV-specific antibodies. 208 
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Biotin was removed from surface proteins by the addition of cleavage buffer (60 mM L-209 
glutathione, 75 mM NaCl, 10 mM EDTA, pH 7.5) for 30 min at 4°C. One sample was neither 210 
incubated nor reduced with cleavage buffer to determine the total amount of biotinylated proteins. 211 
The efficiency of biotin removal by cleavage buffer was determined by cleavage of a non-212 
incubated sample. After lysis of the cells with RIPA lysis buffer (Millipore), biotinylated proteins 213 
were immunoprecipitated using Streptavidin Mag Sepharose (Sigma) and then separated by 214 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis under non-reducing conditions. The 215 
presence of RSV F proteins was detected by transferring the gel to a PVDF membrane and 216 
subsequent incubation with RSV F specific mAb. 217 
 218 
Internalization inhibition assays 219 
To inhibit antibody-induced internalization, two strategies were performed as previously reported 220 
(35). First, inhibitors were used in different concentrations before and during the internalization 221 
assay. Amantadine and nystatin, purchased from Sigma, and myristoylated dynamin inhibitory 222 
peptide (DIP), purchased from Tocris Bioscience, were diluted in their solvent prior to dilution in 223 
cell-culture medium. After 1 h pretreatment of the cells with the inhibitors at 37°C, fresh inhibitor 224 
was added to the cells together with antibodies to induce internalization. As a control for each 225 
drug, cells were incubated with the corresponding solvent of the inhibitor. Controls were applied 226 
to confirm the effectiveness of the drugs, including biotinylated transferrin for clathrin-mediated 227 
endocytosis and FITC-labelled BSA for caveolae-mediated endocytosis. The biotinylated 228 
transferrin was visualized with streptavidin-FITC. Second, inhibition of internalization was 229 
performed using plasmids encoding dominant negative (DN) proteins that inhibit clathrin-, 230 
caveolae- or dynamin-mediated endocytosis. These constructs and their wild-type (WT) 231 
counterparts were originally provided by A. Benmerah (36, 37), A. Helenius (38, 39) and M. 232 
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McNiven (40, 41) respectively and further modified as described before (42). Co-transfection of 233 
BSR T7/5 cells was performed by diluting equal amounts of DNA of the RSV F protein and the 234 
DN or WT protein. WT and DN dynamin 2(aa) with a C-terminal enhanced GFP (eGFP) tag, 235 
were used to inhibit dynamin-dependent endocytosis. To inhibit clathrin-mediated endocytosis, 236 
the DN mutant of the protein Eps15 (DIII), essential for the docking of adaptor protein-2 during 237 
assembly of clathrin-coated pits, was used (42). This EGFP-tagged mutant has a deletion at the 238 
Eps15 homology and coiled-coil domains. A construct with a supplementary deletion of the AP-239 
2-binding site served as a negative control (D3Δ2). WT and DN caveolin-1 constructs were used 240 
for caveolae-mediated endocytosis. 241 
 242 
Microscopic analysis 243 
All high-resolution images of monolayer cultures were obtained using Apotome 2 with a Axio 244 
Observer inverted microscope with a compact light source HXP 120C (Zeiss) and using a Nikon 245 
Eclipse Ti-E inverted microscope attached to a microlens-enhanced dual spinning disk confocal 246 
system (UltraVIEW VoX; PerkinElmer, Zaventem,Belgium) equipped with 405 and 488 nm 247 
diode lasers for excitation of blue and green fluorophores, respectively. The images were 248 
obtained with ZEN 2012 and Volocity 3D Image Analysis Software.WD-PBEC imagese were 249 
obtained with a Nikon eclipse 90i inverted microscope. 250 
 251 
Statistical analysis 252 
Data are presented as means (±SD) of three independent repeats and were analyzed by a student’s 253 
t-test using GraphPad Prism 6. P values <0.05 were considered statistically significant. 254 
 255 
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RESULTS 256 
 257 
Antibody-induced internalization of cell surface-expressed RSV antigens 258 
To evaluate antibody-induced internalization of RSV antigens, RSV-infected HEp-2 and A549 259 
cells were incubated with polyclonal goat anti-RSV IgG for 1 h and subsequently fixed and 260 
stained with AF488 donkey anti-goat IgG. At time point 0, membrane staining was observed for 261 
both cell types and none of the infected cells showed vesicles in their cytoplasm (Fig.1A). After 1 262 
h incubation at 37°C, multiple intracellular vesicles were present in the cytoplasm of the cells and 263 
a reduction in surface expression was observed. No intracellular vesicles were observed in non-264 
infected cells. Isotype control antibodies and secondary antibodies only were used to confirm that 265 
the internalization process is specifically induced by the interaction of  RSV-specific antibodies 266 
with RSV antigens (data not shown). In addition, the kinetics of antibody-induced internalization 267 
was analyzed. Fig.1B shows the kinetics of the percentage of cells positive for intracellular RSV 268 
antigen–antibody complexes, which reached a maximum at 60 min and 90 min for HEp-2 cells 269 
and A549 cells, respectively. Similar observations were made based on the number of 270 
internalized vesicles (Fig.1C). By flow-cytometric analysis, the surface bound antibodies were 271 
measured before and after induction of internalization to allow a more quantitative measurement 272 
of internalization (43, 44). For HEp-2 cells and A549 cells, the mean fluorescence intensity 273 
(MFI) of surface RSV proteins after the addition of antibodies was reduced to 44% and 40%, 274 
respectively, showing that internalization occurs, but that not all RSV proteins are internalized 275 
(Fig.1D). Taken together, antibody-induced internalization of RSV antigens is time-dependent, 276 
but not all molecules are internalized upon binding of pAbs. Addition of increasing 277 
concentrations of pAbs resulted in rising levels of internalized vesicles between 0.001 and 0.01 278 
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mg/ml, followed by a slower increase between 0.01 and 0.3 mg/ml (Fig. 1E). At a concentration 279 
of 1 mg/ml, the internalization efficiency decreased.  280 
Two major antigenic subgroups (A and B) have been described for RSV. With regards to the 281 
RSV surface proteins F and G, an amino acid identity of 91% and 51%, respectively, exists 282 
between the subgroups (45). After infection with the RSV B1 reference strain, internalization of 283 
RSV-specific pAbs in complex with RSV surface antigens was also observed (Fig.2A). 284 
Additionally, a clinical strain (A1998/3-2) was evaluated and numerous intracellular vesicles 285 
were also observed, and surface expression of RSV proteins was reduced compared to time point 286 
0 (Fig.2A). These findings suggest that internalization of RSV surface antigens is a general 287 
feature of RSV. In addition to polyclonal goat anti-RSV antibodies obtained after immunization, 288 
a human anti-RSV reference serum (obtained after natural RSV infection) was also evaluated. 289 
After a 60 min incubation at 37°C, internalization and antigen–antibody complexes were detected 290 
in the cell cytoplasm, and some complexes remained at the surface of infected HEp-2 cells 291 
(Fig.2B). Finally, the internalization process was also analyzed in RSV-infected well-292 
differentiated primary bronchial epithelial cells (WD-PBECs). After 120 min incubation with 293 
human RSV-specific antiserum, internalized RSV antigen–antibody complexes were observed in 294 
more than 80% of the RSV-infected cells (Fig.3A,B). 295 
 296 
Determination of the cell-surface expressed RSV proteins involved in the internalization 297 
process 298 
Since RSV F and G proteins are the two major surface antigens and the only RSV proteins that 299 
induce neutralizing antibodies, the involvement of the respective RSV surface glycoproteins was 300 
identified. For this purpose, RSV glycoprotein-specific mAbs were used. For both surface 301 
proteins and in both cell types, internalization and intracellular vesicles were observed (Fig.4A). 302 
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Analysis of internalization in BSR T7/5 cells transfected with the individual RSV F or G proteins 303 
was performed to investigate their respective roles in this process. Internalization of RSV 304 
antigens was also observed after RSV infection of BSR T7/5 cells and incubation with RSV-305 
specific antibodies, showing that this process also occurs in these cells (data not shown). For both 306 
proteins, multiple internalized antigen–antibody complexes were present in vesicles in the 307 
cytoplasm of cells transfected with the RSV F or G protein and after incubation with either RSV-308 
specific pAbs or RSV glycoprotein-specific mAbs (Fig.4B). These observations show that 309 
internalization of both RSV surface proteins occurs independent of other viral proteins. 310 
 311 
Internalization of surface-expressed RSV F proteins is clathrin-mediated and mainly 312 
triggered after antibody-induced cross-linking of the RSV F protein 313 
As mentioned earlier, RSV F is the major target of neutralizing antibodies and plays a central role 314 
in the development of new immunoprophylaxis and vaccine strategies. Therefore, the 315 
characteristics of RSV F internalization were studied in more detail. The endocytic route through 316 
which RSV F-antibody complexes are internalized, was investigated by using inhibitors that 317 
block different mechanisms of endocytosis. DIP is an inhibitor of the GTPase dynamin that 318 
blocks the binding of dynamin to amphiphysin (46). Addition of this peptide during 319 
internalization resulted in a reduction of approximately 50% of internalized vesicles (Fig.5A). 320 
Inhibition by dynasore, an inhibitor that blocks dynamin by disturbing the plasma membrane 321 
cholesterol homeostasis (47), resulted in similar reductions (data not shown). In addition, BSR 322 
T7/5 cells expressing a recombinant RSV F protein were co-transfected with dominant negative 323 
(DN) proteins to inhibit a specific internalization process. By using an eGFP-tagged DN mutant 324 
of dynamin 2(aa) in RSV F transfected BSR T7/5 cells, a significant reduction of internalized 325 
vesicles (62.01%) was observed in cells transfected with DN dynamin compared to WT dynamin 326 
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transfected cells (Fig.5B,G). Both results show the involvement of a dynamin-dependent 327 
mechanism. Since GTPase dynamin is recruited to both clathrin-coated pits and caveolae, further 328 
distinction was made between these endocytic routes (48). Amantadine was used to test the 329 
dependence of clathrin and resulted in a dose-dependent reduction of intracellular vesicles with a 330 
maximum of 74.09% (Fig.5C). By using a DN mutant of Eps 15 (DIII) and the control plasmid 331 
DIIIΔ2 the role of clathrin was further analyzed. DIII transfected cells showed a significant 332 
reduction in internalization compared to DIIIΔ2 transfected cells (Fig.5D,G). No difference in the 333 
amount of internalized vesicles was observed after treatment of the cells with nystatin, a sterol-334 
binding agent which disrupts caveolae (Fig.5E). These results were confirmed in RSV F 335 
transfected cells co-transfected with a GFP-tagged DN mutant of caveolin-1, which showed no 336 
significant differences in internalization of RSV F compared to cells transfected with the control 337 
plasmid, an eGFP-tagged WT caveolin-1 (Fig.5F,G). 338 
In addition, we investigated the extent to which spontaneous endocytosis occurs for RSV 339 
proteins by labelling the surface proteins of infected cells with a membrane impermeable 340 
biotinylation reagent, followed by an internalization assay. Cell surface biotinylation was 341 
efficient (Fig.6E) and the addition of cell-impermeable glutathione removed almost all biotin 342 
from the cell surface (Fig.6D). Antibody-induced internalization of biotinylated surface proteins 343 
resulted in protection from glutathione-mediated biotin cleavage. A difference in the amount of 344 
intracellular (biotinylated) RSV F proteins could be observed between internalization induced by 345 
antibodies (Fig.6C) and spontaneous endocytosis in the absence of antibodies (Fig.6B), 346 
confirming that the majority of RSV F internalization is triggered by antibodies. 347 
Intact monoclonal IgG antibodies can cross-link surface-expressed antigens and stimulate their 348 
internalization (49, 50). To determine whether cross-linking of RSV F proteins is required for 349 
internalization, monovalent Fab fragments of RSV F-specific mAbs were compared with the 350 
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intact mAbs (Fig.7A). Internalization of RSV F proteins was significantly reduced when induced 351 
by the monovalent Fab fragments (Fig.7B), indicating that cross-linking plays a role in efficient 352 
RSV F internalization.  353 
 354 
Internalization of surface RSV F proteins is triggered by binding of different neutralizing 355 
RSV F epitope-specific mAbs 356 
Different neutralizing epitopes on the RSV F protein have already been identified and mAbs 357 
directed against these epitopes are available (10, 13-15). Since mAbs recognizing different 358 
epitopes of the same protein could have different effects on internalization, the epitope-359 
dependence of RSV F internalization was analyzed (51). The amount of internalized RSV F-mAb 360 
complexes was determined by flow-cytometric analysis. After shifting RSV-infected HEp-2 cells 361 
in suspension to 37°C, anti-RSV F mAbs attached to surface RSV F proteins were internalized 362 
and the amount of internalization was quantified by a reduction of surface expression. A 363 
reduction in MFI was seen for all mAbs, compared to the MFI of cells that were kept at 4°C and 364 
did not undergo internalization. The amount of internalization, as calculated by the reduction of 365 
surface fluorescence, ranged from 31 to 57% for mAb 131-2A and AM22, respectively. Overall, 366 
no major differences could be observed between prefusion RSV F-specific mAbs or mAbs that 367 
bound both pre- and postfusion RSV F (Table 1). The results also showed that not all RSV F 368 
molecules are internalized upon stimulation with the mAbs. These findings were confirmed by 369 
analysis with fluorescence microscopy where surface expression of RSV F was still observed 370 
after induction of internalization (data not shown). 371 
 372 
DISCUSSION 373 
 374 
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Our results show the potential of RSV-specific antibodies and human sera from RSV-infected 375 
patients to trigger internalization of RSV antigens expressed on the surface of infected cells. 376 
These findings were clearly documented by confocal microscopic analysis and flow cytometry, 377 
and observed in different epithelial cell lines (HEp-2, A549 and BEAS-2B cells (52, 53). In 378 
addition, WD-PBEC cultures were used to confirm that this process also occurs in a more 379 
representative model of primary airway epithelial cells. The amount of intracellular vesicles 380 
increased with increasing time of incubation and reached a plateau after 60 to 90 min in 381 
monolayer cells. Furthermore, surface-expressed glycoproteins of different RSV strains, 382 
including both reference strains (A2 and B1) and a clinical isolate (A1998/3-2), were shown to be 383 
susceptible to antibody-induced internalization (54). Taken together, our findings suggest that the 384 
internalization process is a general feature of RSV-infected cells. Using inhibitors and plasmids 385 
encoding dominant-negative proteins of endocytic pathways, the internalization was shown to be 386 
clathrin-dependent. However, since complete inhibition of RSV F internalization was not 387 
achieved, other mechanisms might be involved or could be induced upon blocking a specific 388 
pathway (55). To exclude the latter possibility, combinations of inhibitors were tested but did not 389 
show any difference compared to treatment with a single inhibitor (data not shown) (56).  390 
Additionally, it was shown that RSV F internalization is mainly triggered upon binding of 391 
antibodies and is not merely spontaneous internalization, a well-described feature of several 392 
paramyxoviruses (18, 19, 21, 23). The results of a biotin internalization assay showed 393 
internalization of RSV F proteins after Ab-triggering. Only a weak signal was observed in the 394 
absence of antibodies to induce internalization, which might be a consequence of membrane 395 
turnover or residual non-cleaved proteins. Interestingly, a reduction in the molecular weight of 396 
the RSV F protein was observed upon internalization. A possible explanation is that upon 397 
internalization, an event occurs which cleaves the disulphide bridge between F1 and F2 subunits. 398 
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This can be mediated by the presence of enzymes in the endo-lysosomal system that reduce 399 
disulphide bonds and would thus also cleave the F1-F2 bonds (57, 58). Since the mAb used in 400 
this experiment is specific for F1, this cleavage will result in detection of a lower molecular 401 
weight band on WB, corresponding to the F1 subunit. In addition to binding, antibody-induced 402 
cross-linking is most likely needed since we observed that RSV F protein-specific, monovalent 403 
Fab fragments were not efficient in inducing internalization. Furthermore, at the highest Ab 404 
concentration tested, internalization was induced less efficiently. This could indicate that with 405 
high antibody concentrations, cross-linking of RSV F proteins does not efficiently occur because 406 
every F protein is bound by a different antibody and thereby cross-linking induced internalization 407 
signals would be lost. 408 
Previous work showed that internalization of surface-expressed viral glycoproteins can be 409 
influenced by interactions with other viral proteins expressed in infected cells. For the Suid 410 
herpesvirus I glycoproteins gB and gD, antibody-induced cross-linking was shown to be required 411 
for efficient internalization in infected monocytes (22). In contrast, viral core proteins of measles 412 
virus are known to regulate the expression of viral glycoproteins and may inhibit internalization 413 
during infection to promote virus assembly (18). In our work, internalization was observed in 414 
cells transfected with a single RSV protein as well as in RSV-infected cells, indicating that RSV 415 
F internalization occurs independently and is not affected by the expression of other viral 416 
proteins. How exactly RSV F activates internalization upon antibody binding is not clear. For 417 
some viruses, it was shown that internalization can depend on specific endocytic motifs in 418 
cytoplasmic and/or transmembrane domain of the viral protein, such as common tyr-based motifs 419 
and di-leu motifs (18, 29, 30, 59). For other viruses, it is less clear that internalization depends on 420 
specific motifs and internalization may result from cross-linking. Analysis of the cytoplasmic tail 421 
of the RSV F protein did not reveal any known amino acid motifs involved in internalization. 422 
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Furthermore, analysis of antibody-induced internalization using a mutant RSV F protein lacking 423 
the cytoplasmic tail, only resulted in approximately 30% reduction of internalization (data not 424 
shown). This suggests that for RSV, specific amino acid motifs are not involved, and that cross-425 
linking is a major driver for internalization, consistent with our finding that monovalent Fab 426 
fragments cannot efficiently induce internalization. 427 
Several neutralizing RSV F-specific mAbs are described (Table 1). For some mAbs, it is 428 
shown that neutralization results from blocking virus fusion with host cell membranes by fixing 429 
RSV F proteins in their prefusion conformation (14, 60). Interestingly, their neutralizing activity 430 
may not only be directed against virions but also against virus-infected cells since cell-to-cell 431 
fusion can be inhibited by mAbs like palivizumab and motavizumab (60). In this study, flow-432 
cytometric analysis showed that all RSV F-specific mAbs tested had the ability to decrease 433 
surface expression of RSV F proteins, which may impact cell-to-cell fusion. While this 434 
internalization may not affect cell-to-cell fusion for mAbs that directly block the RSV F fusion 435 
activity, it can still affect cell-to-cell fusion indirectly for mAbs that do not interfere with the 436 
RSV F fusion activity. As previously shown, different epitope recognition by mAbs could change 437 
the internalization pattern of the target antigen (51). However, we observed no differences 438 
between the different mAbs, all specific for one of the 6 known RSV F epitopes. These findings 439 
suggest that the antibody-induced internalization process of RSV F is not epitope-dependent. 440 
Reinfection with RSV can occur throughout life, indicating that RSV antibody responses only 441 
partially provide protection and only for a limited period of time (2, 61). Prophylactic 442 
palivizumab is able to prevent severe RSV-induced respiratory tract disease in most, but not in all 443 
patients. The cause of the partial failure of this immunoprophylaxis remains unknown, but could 444 
be attributed to variations in the dose of inoculum, the efficiency of Ab transfer to the airways 445 
and the size of the airways. The process we observed may also affect the activity of anti-F 446 
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antibodies if the internalization strongly decreases the amount of RSV-specific antibodies. 447 
Presumably, this decrease will not be sufficient to impair the neutralization of free virus particles. 448 
Furthermore, the process we observed may also result in an antiviral effect, since internalization 449 
of the F protein could interfere with the formation of virus particles and spreading of the virus 450 
would thus be restricted already early in infection. On the contrary, interference in effector-451 
mediated destruction of virus-infected cells by this process is more likely. In HIV-1 and SIV-452 
infected cells, internalization of Env proteins provided protection from elimination by antibody-453 
dependent cell-mediated cytotoxicity. Based on these findings, it was suggested that the efficacy 454 
of antibody-based therapeutics and HIV-1 vaccines could be improved by disturbing Env 455 
internalization (63). For herpesviruses, a similar observation was made (25). Surface expressed 456 
virus proteins were internalized by addition of specific antibodies, and antibody-dependent 457 
complement-mediated cell lysis was reduced approximately by 50% in infected cells upon 458 
antibody-induced internalization (25). Our results showed a remarkable decrease of surface-459 
expressed F proteins after internalization, yet a portion remained on the cell surface. In this 460 
regard, further research is needed to elucidate whether there is sufficient internalization to protect 461 
RSV-infected cells from antibody-mediated effector responses. 462 
In conclusion, this study describes a mechanism by which the RSV proteins expressed on the 463 
surface of infected cells are removed from the cell surface, together with RSV-specific 464 
antibodies, by internalization. Whether this process affects the activity of RSV F-specific 465 
antibodies and also has consequences for the in vivo replication and immune response remains to 466 
be elucidated.  467 
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FIGURE LEGENDS 687 
 688 
FIG 1 Antibody-induced internalization of RSV antigens. (A) HEp-2 cells and A549 cells 689 
were infected with RSV A2 for 24 h and then incubated with a pAb goat anti-RSV antibody 690 
bound at 4°C and then shifted to 37°C for 1 h to induce internalization. Afterwards the cells were 691 
fixed, permeabilized and stained with AF 488 donkey anti-goat IgG (green). Nuclei were 692 
visualized with DAPI (blue). Images represent a single confocal z-section through the middle of 693 
the cell. (B) Kinetics of the percentage of cells with internalized RSV antigen–antibody 694 
complexes for the indicated time points. (C) Kinetics of the amount of internalized vesicles in 695 
positive cells for the indicated time points. (D) Flow-cytometric analysis of RSV internalization. 696 
RSV-infected HEp-2 and A549 cells were kept in suspension during the induction of 697 
internalization and staining of the cells. The level of the remaining surface expressed RSV 698 
antigens after internalization is expressed as MFI relative to T0. (E) Effect of increasing 699 
concentrations of pAb goat anti-RSV antibodies on internalization. For each antibody 700 
concentration, the amount of internalized vesicles was quantified in 50 positive cells. Data 701 
represents the means (± SD) of 3 independent repeats. 702 
FIG 2 Antibody-induced internalization of RSV antigens with different RSV strains and 703 
different serum. (A) HEp-2 cells were infected with RSV reference strain B1 or the clinical 704 
strain A1998/3-2 during 24 h. Goat anti-RSV pAbs were bound at 4°C (0 min) and internalization 705 
was induced at 37°C (60 min). (B) Human reference antiserum was used to induce internalization 706 
in RSV A2 infected HEp-2 cells. The cells of A and B were fixed, permeabilized, stained with 707 
AF 488 donkey anti-goat IgG and donkey anti-human IgG (green) respectively, and stained with 708 
DAPI (blue). 709 
 o
n
 M
ay 9, 2017 by QUEEN'S UNIVERSITY BELFAST
http://jvi.asm.org/
D
ow
nloaded from
 
29 
 
FIG 3 Antibody-induced internalization of RSV antigens in WD-PBECs. WD-PBEC cultures 710 
were infected with RSV/A2 mKate (MOI=3) in duplicate. At 72 h post infection, cultures were 711 
incubated with human sera for 1 h at 4°C, washed and then transferred to 37°C. Cultures were 712 
fixed at 0, 90 and 120 min with 4% paraformaldehyde,  permeabilized and incubated with anti-713 
human IgG FITC secondary for 1 h at 37°C. Images for data presented in A-C were taken using a 714 
Nikon Eclipse 90i microscope. Images for D were taken with a Leica SP5 confocal microscope. 715 
(A) 100 mKate positive RSV-infected cells at each time point in duplicate examined for evidence 716 
of internalized antibody using. (B) Representative images at each time point blue (DAPI), red 717 
(mKate), green (anti-human IgG 488 antibody). (C) Mock-infected cells incubated with sera for 718 
90 or 120 min and stained with the anti-human IgG 488 antibody. (D) En face and corresponding 719 
orthogonal sections with blue (DAPI), green (anti-human IgG 488 antibody). The confocal 720 
settings and gain were kept constant for all conditions. 721 
FIG 4 Antibody-induced internalization of RSV surface glycoproteins F and G. (A) RSV 722 
infection of HEp-2 and A549 cells during 24 h was followed by incubation of the cells with anti-723 
RSV F (clone 131-2A) or anti-RSV G (clone 131-2G) specific mouse mAbs for 1 h at 37°C. (B) 724 
RSV F and RSV G transfected BSR T7/5 cells were incubated with pAb goat anti-RSV or the 725 
corresponding mAbs during 1 h. At the indicated time points, the cells were fixed, permeabilized 726 
and stained with appropriate AF 488-conjugated secondary antibodies (green) and DAPI (blue). 727 
Images were acquired by fluorescence microscopy. 728 
FIG 5 Effect of inhibitors and DN proteins on antibody-induced RSV F internalization. 729 
RSV-infected HEp-2 cells were incubated with mAb 131-2A in the presence of different 730 
concentrations of endocytic inhibitors, DIP (A), amantadine (C) and nystatin (E). After 90 min 731 
incubation, cells were fixed, permeabilized and stained. The amount of intracellular vesicles was 732 
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quantified and expressed as percentage relative to the number of vesicles in the absence of the 733 
inhibitor. BSR T7/5 cells were co-transfected with both RSV F (red) and DN proteins (dynamin 2 734 
(B), Eps15 (DIII) (D) and caveolin-1 (F)) (green). For each DN protein, also a control construct 735 
was used (WT dynamin 2 (B), inactive Eps15 (D3Δ2) (D), WT caveolin-1 (F)). After induction 736 
of internalization and staining of the cells, the amount of internalized vesicles was determined by 737 
fluorescence microscopy. Data represents the mean (±SD) of three replicates. (*, P < 0.05). 738 
FIG 6 Western blot analysis of a biotin internalization assay of RSV F proteins. RSV-739 
infected and non-infected HEp-2 cells were biotin labeled using a membrane impermeable 740 
biotinylation reagent. The cells were shifted with or without antibodies to 37°C during 90 min to 741 
allow endocytosis. Non-internalized biotinylated surface proteins were removed by cleavage with 742 
glutathione, while internalized proteins were protected from biotin removal. After cell lysis, 743 
biotinylated proteins were immunoprecipitated using Streptavidin Mag Sepharose, separated by 744 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis under non-reducing conditions and 745 
detected with RSV F specific antibodies. (A) Sample of non-infected cells. (B) Internalized RSV 746 
F proteins after incubation at 37°C. (C) Internalized RSV F proteins after incubation with RSV F 747 
specific antibodies. (D) Amount of biotinylated surface RSV F proteins after cleavage with 748 
glutathione. (E) Total amount of biotinylated surface RSV F proteins before 37°C incubation 749 
step. A representative blot of a duplicate experiment is shown. 750 
FIG 7 Internalization of Fab fragments. RSV-infected HEp-2 cells were incubated with RSV F 751 
specific mAbs D25, AM14, 5C4, MPE8 or corresponding monomeric Fab fragments at the same 752 
concentration during 90 minutes to induce internalization. Afterwards the cells were fixed, 753 
permeabilized and stained with AF488 human anti-goat IgG or AF488 chicken anti-mouse IgG 754 
(green). Nuclei were visualized with DAPI (blue). The amount of internalized vesicles was 755 
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quantified in 50 positive cells. Results are shown as means (±SD) of three independent replicates. 756 
(*, P < 0.05). 757 
TABLE 1 The capacity of different RSV F-specific mAbs to induce internalization. RSV-758 
infected HEp-2 cells in suspension were incubated with the indicated anti-RSV F mAbs during 1 759 
h at 4°C followed by a shift to 37°C to induce internalization of the attached antibodies. After 760 
staining the cells with secondary antibodies, the mean fluorescence intensity (MFI) was measured 761 
by flow cytometry. The reduction is expressed as percentage relative to T0 (100%). Data 762 
represents the mean of 3 independent repeats.                  763 
RSV F-specific 
mAb 
% reduction  
±SD 
RSV F 
antigenic site 
RSV F 
conformation 
Reference 
131-2A (murine) 31 ± 9 I Post (±pre) (64) 
101F (murine) 47 ± 15 IV Pre and post (13) 
palivizumab 40 ± 18 II Pre and post (4) 
motavizumab 34 ± 17 II Pre and post (65) 
AM22 57 ± 2 Ø Pre (14) 
D25 50 ± 16 Ø Pre (14) 
5C4 (murine) 39 ± 14 Ø Pre (14) 
MPE8 44 ± 9 III Pre (15) 
AM14 42 ± 17 V Pre (17) 
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